Surterra Enters $100 Million Cannabinoid Biosynthesis Deal with Intrexon

Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production Exclusive Global Agreement to Transform Surterra’s Ability to Produce Specific Cannabinoids to Meet Growing Demand, Boost Innovation and Product Development BUDAPEST, Hungary and ATLANTA, June 18, 2019 /PRNewswire/ — Intrexon Corporation (Intrexon) (NASDAQ: XON), a leader in the engineering […]

READ MORE: https://www.newcannabisventures.com/surterra-enters-100-million-cannabinoid-biosynthesis-deal-with-intrexon/